- Home
- PHAT vs AMAL Comparison
PHAT vs AMAL Comparison
Compare PHAT & AMAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAT
- AMAL
- Stock Information
- Founded
- PHAT 2018
- AMAL 1923
- Country
- PHAT United States
- AMAL United States
- Employees
- PHAT N/A
- AMAL N/A
- Industry
- PHAT Biotechnology: Pharmaceutical Preparations
- AMAL Commercial Banks
- Sector
- PHAT Health Care
- AMAL Finance
- Exchange
- PHAT Nasdaq
- AMAL Nasdaq
- Market Cap
- PHAT 769.0M
- AMAL 760.6M
- IPO Year
- PHAT 2019
- AMAL 2018
- Fundamental
- Price
- PHAT $13.55
- AMAL $27.26
- Analyst Decision
- PHAT Strong Buy
- AMAL Hold
- Analyst Count
- PHAT 5
- AMAL 2
- Target Price
- PHAT $17.60
- AMAL $33.00
- AVG Volume (30 Days)
- PHAT 1.3M
- AMAL 175.0K
- Earning Date
- PHAT 10-30-2025
- AMAL 10-23-2025
- Dividend Yield
- PHAT N/A
- AMAL 2.02%
- EPS Growth
- PHAT N/A
- AMAL N/A
- EPS
- PHAT N/A
- AMAL 3.32
- Revenue
- PHAT $147,190,000.00
- AMAL $306,912,000.00
- Revenue This Year
- PHAT $213.65
- AMAL $9.82
- Revenue Next Year
- PHAT $91.41
- AMAL $11.11
- P/E Ratio
- PHAT N/A
- AMAL $8.21
- Revenue Growth
- PHAT 460.30
- AMAL 1.28
- 52 Week Low
- PHAT $2.21
- AMAL $25.03
- 52 Week High
- PHAT $19.50
- AMAL $38.19
- Technical
- Relative Strength Index (RSI)
- PHAT 58.66
- AMAL 49.04
- Support Level
- PHAT $13.02
- AMAL $27.04
- Resistance Level
- PHAT $16.08
- AMAL $28.08
- Average True Range (ATR)
- PHAT 1.05
- AMAL 0.85
- MACD
- PHAT -0.02
- AMAL 0.14
- Stochastic Oscillator
- PHAT 44.88
- AMAL 58.36
About PHAT Phathom Pharmaceuticals Inc.
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.
About AMAL Amalgamated Financial Corp. (DE)
Amalgamated Financial Corp is a bank holding company. It is a full-service commercial bank and a chartered trust company. It provides commercial banking and trust services nationally and offers various products and services to commercial and retail customers. It offers a complete suite of commercial and retail banking, investment management and trust and custody services.